Home Featured Page 217

Featured

Latest

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next

The Optimisation Problem: What Bryan Johnson’s 5-MeO-DMT Experiment Reveals About Psychedelics Going Mainstream

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid...

Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human...

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent...

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for...

Eyes on Oregon, a Psychedelics Today Podcast with Jon Dennis and...

Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

Psychedelic Bypassing: When Avoidance is Mistaken for Healing

MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease

EDITOR PICKS

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive...

The Optimisation Problem: What Bryan Johnson’s 5-MeO-DMT Experiment Reveals About Psychedelics...

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next

The Optimisation Problem: What Bryan Johnson’s 5-MeO-DMT Experiment Reveals About Psychedelics Going Mainstream

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid...

Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human...

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent...

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for...

Eyes on Oregon, a Psychedelics Today Podcast with Jon Dennis and...

Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

Psychedelic Bypassing: When Avoidance is Mistaken for Healing

MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease

EDITOR PICKS

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive...

The Optimisation Problem: What Bryan Johnson’s 5-MeO-DMT Experiment Reveals About Psychedelics...

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY